SCHEMBL29822698

SCHEMBL29822698

CN(C)c1ccccc1-c1ccccc1P(c1ccccc1)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.41
MAPT P10636 3/20 0.41
TDP1 Q9NUW8 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
NSD2 O96028 1/20 0.41
EGFR P00533 1/20 0.41
LMNA P02545 1/20 0.41
MAPK1 P28482 1/20 0.41
CYP3A4 P08684 1/20 0.39
DRD1 P21728 2/20 0.37
GAA P10253 2/20 0.33
HTR6 P50406 2/20 0.33
TP53 P04637 1/20 0.33
TSHR P16473 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
MEN1 O00255 1/20 0.33
RAB9A P51151 1/20 0.33
KMT2A Q03164 1/20 0.33
PTK2B Q14289 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29444117 1.00 ALDH1A1 (0.41) ALDH1A1MAPTTDP1L3MBTL1NSD2
SCHEMBL229536 1.00 ALDH1A1 (0.41) ALDH1A1MAPTTDP1L3MBTL1NSD2
Bromide SCHEMBL1033291 0.96 ALDH1A1 (0.39) ALDH1A1MAPTTDP1L3MBTL1NSD2
SCHEMBL1033292 0.93 ALDH1A1 (0.37) ALDH1A1MAPTTDP1L3MBTL1NSD2
SCHEMBL2523285 0.89 TDP1 (0.34) ALDH1A1MAPTTDP1L3MBTL1NSD2
SCHEMBL29513054 0.86 MAPT (0.50) ALDH1A1MAPTTDP1L3MBTL1NSD2
SCHEMBL17606910 0.86 MAPT (0.50) ALDH1A1MAPTTDP1L3MBTL1NSD2
SCHEMBL1768181 0.84 MAPT (0.49) ALDH1A1MAPTTDP1L3MBTL1NSD2
SCHEMBL1622430 0.84 TDP1 (0.46) ALDH1A1MAPTTDP1L3MBTL1NSD2
Bromide SCHEMBL7609603 0.82 TDP1 (0.44) ALDH1A1MAPTTDP1L3MBTL1NSD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119053608-A Novel compound, conjugated polymer, method for producing same, composition for film formation, organic thin film, and organic semiconductor element 东曹株式会社 2024-11-29 CN disclosed
CN-118434704-A Bimantane compound, material for organic electroluminescent device, and organic electroluminescent device 东曹株式会社 2024-08-02 CN disclosed
US-20240018121-A1 NOVEL HETEROAROMATIC COMPOUNDS EXHIBITING ANTIFUNGAL ACTIVITY AND THEIR METHOD OF USE FOX CHASE CHEMCIAL DIVERSITY CENTER, INC. (US) 2024-01-18 US disclosed
WO-2023068017-A1 ORGANIC SEMICONDUCTOR MATERIAL 東洋紡株式会社 2023-04-27 WO disclosed
CN-111592567-B Synthesis method of bidentate phosphine ene ligand 湖北大学 2023-01-10 CN disclosed
CN-114967329-A Colored resin composition, compound, color filter and display device 住友化学株式会社 2022-08-30 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240018121-A1 NOVEL HETEROAROMATIC COMPOUNDS EXHIBITING ANTIFUNGAL ACTIVITY AND THEIR METHOD OF USE ERG28, CYP51A1, MANBA ALDH1A1 1109/4885MAPT 987/4885TDP1 1938/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.